Insider Transactions in Q4 2023 at Optimize Rx Corp (OPRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2023
|
Marion Odence Ford General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
524
-3.35%
|
$4,716
$9.21 P/Share
|
|
Nov 08
2023
|
Marion Odence Ford General Counsel and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,785
+10.25%
|
-
|
|
Nov 01
2023
|
Theresa Greco Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,519
+33.33%
|
-
|
|
Oct 11
2023
|
Edward Stelmakh CFO/COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,066
-6.54%
|
$14,462
$7.15 P/Share
|
|
Oct 11
2023
|
Edward Stelmakh CFO/COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,155
+16.3%
|
-
|
|
Oct 03
2023
|
Doug Besch Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
976
-20.23%
|
$6,832
$7.06 P/Share
|
|
Oct 03
2023
|
Doug Besch Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,324
+40.8%
|
-
|
|
Oct 03
2023
|
Edward Stelmakh CFO/COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,117
-19.29%
|
$28,819
$7.06 P/Share
|
|
Oct 03
2023
|
Edward Stelmakh CFO/COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,662
+43.84%
|
-
|
|
Oct 03
2023
|
Stephen L Silvestro Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,952
-29.36%
|
$13,664
$7.06 P/Share
|
|
Oct 03
2023
|
Stephen L Silvestro Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,649
+50.0%
|
-
|
|
Oct 03
2023
|
Marion Odence Ford General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,952
-12.35%
|
$13,664
$7.06 P/Share
|
|
Oct 03
2023
|
Marion Odence Ford General Counsel and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,649
+29.61%
|
-
|